A new wave of gene therapies ready to hit US shores – BioPharma Dive
|
A new wave of gene therapies ready to hit US shores
BioPharma Dive The first ever approved gene therapy was Shenzhen SiBiono GenTech's Gendicine, a recombinant Ad-p53 gene therapy for head and neck cancer, which launched in China in 2004. But it was Glybera's (alipogene tiparvovec) approval in fall 2012 that … |
